Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2008 Results
Date:10/30/2008

G&A expenses in the third quarter of 2008 relative to the second quarter of 2008 is primarily due to lower iloperidone pre-commercial launch expenses. The decrease in G&A expenses in the third quarter of 2008 relative to the third quarter of 2007 is primarily due to lower employee stock-based compensation expense and lower iloperidone pre-commercial launch expenses.

-- Employee stock-based compensation expense recorded in the third quarter of 2008 totaled $3.6 million. Of these non-cash charges, $0.5 million was recorded as R&D expense and $3.1 million was recorded as G&A expense. In the second quarter of 2008 and the third quarter of 2007, total stock-based compensation was $4.0 million and $5.2 million, respectively. The decrease in stock-based compensation in the third quarter of 2008 relative to the second quarter of 2008 and the third quarter of 2007 is primarily due to the lower fair market value of options granted in 2008.

-- Net loss for the third quarter of 2008 was $10.9 million, compared to a net loss of $13.5 million for the second quarter of 2008 and $21.9 million for the third quarter of 2007.

-- Net loss per common share for the third quarter of 2008 was $0.41, compared to $0.51 for the second quarter of 2008 and $0.82 for the third quarter of 2007.

-- Cash and marketable securities decreased by $13.9 million during the third quarter of 2008. Changes included $10.9 million of net losses, decreases in accrued R&D expenses and accounts payable of $5.2 million, net increases in prepaid expenses of $0.9 million, fixed asset purchases of $0.5 million offset by $3.7 million in non-cash depreciation, amortization, and stock-based compensation expenses and net increases in other working capital of $0.1 million.

-- Vanda's cash, cash equivalents, and marketable securities as of September 30, 2008 totaled approximately $51.7 million, compared to approximately $93.2 million as of December 31, 2007.

FINANCIAL GUIDANCE '/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the White House will ... from across the United States to talk about their experiences with innovation and present ... to be among the attendees. , One of the day’s aims is to grow ...
(Date:8/4/2015)... LOS ANGELES , Aug. 4, 2015   ... announced the recent acquisition of LifeLine Cryogenics, an east ... the New York tristate area. ... tissues, and all prepaid contracts will be honored. ... of cryogenics services, offering storage of sperm, eggs, embryos, ...
(Date:8/4/2015)... 4, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ... China , today announced that it will ... ended June 30, 2015, after market close on Wednesday, ... on Thursday, August 13, 2015, at 8:00 a.m. EDT ... Time) to review the Company,s financial results and provide ...
(Date:8/3/2015)... 2015  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... second quarter 2015 on Monday, August 10, 2015 at ... , president and chief executive officer, will lead the ... financial results for the second quarter 2015. ... section of Halozyme,s corporate website and a recording will ...
Breaking Biology Technology:White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2FamilyCord Announces Acquisition of LifeLine Cryogenics 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2
... - The June 30 deadline is approaching for ... $223.9 million in benefits from a class action ... attorneys lawyers involved in the court-approved settlement. ... Wisconsin's antitrust and unfair competition laws. , ,The ...
... - Abandoned and failed information technology programs have cost state ... trend that has some members of the Legislature wondering if ... reprogram the whole mess. , ,There's probably no need to ... government's cut-and-paste IT operations. Instead, lawmakers should look for best ...
... - Since it was founded in 1998, EMSystem ... of web-based communications and resource management for hospitals and emergency ... attained that stature or gotten off the ground at all ... is, in the words of one of its founders, one ...
Cached Biology Technology:June 30 is deadline to claim up to $223.9M in Microsoft settlement 2Ethics Board site offers welcome contrast to state IT mistakes 2Ethics Board site offers welcome contrast to state IT mistakes 3Pre-eminent, web-based companies owe success to corporate venturing 2Pre-eminent, web-based companies owe success to corporate venturing 3Pre-eminent, web-based companies owe success to corporate venturing 4Pre-eminent, web-based companies owe success to corporate venturing 5Pre-eminent, web-based companies owe success to corporate venturing 6
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... solutions, today announced that members of the executive management ... Pacific Crest Global Technology Leadership Forum on Tuesday, August ... will be held at the Sonnenalp Resort in ... presentation may include forward-looking information. An audio webcast of ...
(Date:7/31/2015)... Kina, 31. juli 2015 Den 10. internationale ... af BGI fra den 22. - 25. oktober i ... fejrer sin 10-års fødselsdag i år. Siden starten i ... årlige møder på ,omik,-feltet, og er en af de ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden ...
(Date:7/31/2015)... 31 de julio de 2015 BGI llevará a ... ) del 22 al 25 de octubre de 2015, ... La conferencia celebra su décimo aniversario este año. Desde ... una de las reuniones anuales más influyentes del mundo ... de las conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... A new research study at the University of Delaware ... microorganism that lives in seawater and is related to ... and virulence. V. parahaemolyticus is a ... with the consumption of raw or undercooked seafood, particularly ...
... dogs in western and central Africa comes from a ... ago, probably by European colonialists. In the current issue ... of scientists from Africa, USA and France report that ... country level and that there is only limited movement ...
... beneficial effect of anakinra for rheumatoid arthritis patients, but ... use with other biologic medications. Rheumatoid arthritis is ... in 100 people worldwide. It affects the joints, making ... new breed of arthritis drugs licensed in the past ...
Cached Biology News:UD research study to shed light on emerging seaborne pathogen 2UD research study to shed light on emerging seaborne pathogen 3Hope for a rabies eradication strategy in Africa 2Anakinra for rheumatoid arthritis: A modest benefit with some risk 2
Cells are grown in triple flasks or roller bottles. Viability and growth data are generated from a parallel representative culture....
... Agencourt offers SNP loci identification through ... automated assay design, intensive assay validation/optimization, ... of Corriell or customer-supplied samples and ... service provides for rapid and highly ...
... Agencourt offers pre-validated SNP ... 1500 amplicons within 93 ... kinases, and more than ... These assays were developed ...
... aqueous-based mounting medium designed for the ... is especially recommended when using tracers ... It can also be used with ... (FITC), Rhodamine (TMRITC) and Texas Red. ...
Biology Products: